Herpesviruses are important human pathogens that result in life-long persistent infections with numerous clinical manifestations. Herpes simplex virus (HSV) is among the most frequently encountered pathogen by the general population. Thus understanding the biology of this virus is important in the development of efficacious treatments of these infections. Our goal is to understand the mechanism by which the virus acquires its infectious coat and the role of the virus encoded functions in this pathway, primarily by analyzing the functions of two tegument proteins, the UL36 and UL37 gene products. Our hypothesis is that the UL36 and UL37 gene products specify essential and unique functions for the maturation of the assembled particle into an infectious virion. The goals of this proposal are to understand how these two proteins function in the morphogenesis of the infectious particle, identification of the functional domains required for these activities and the interactions that occur during this process. This could potentially lead to the discovery of novel pathways that can be targeted by antiviral intervention.
The specific aims to achieve these goals are:
Specific Aim 1 : Investigating the role of UL36 and UL37 in the maturation of the virus particle using mutant viruses. UL36 may act to translocate capsids to the cytoplasmic site for final envelopment, whereas, UL37 is required for Golgi stabilization prior to the arrival of capsids at this site. Light microscopy, electron microscopy and immuno-EM assays will be used to determine the association of UL36 mutant virus particles with the cellular cytoskeleton and analyze axonal transport in primary neurons. The Golgi structure will be analyzed in the presence and absence of UL37 and the contribution of UL36, capsid assembly and cis-acting signals for facilitating Golgi stabilization will be determined.
Specific Aim 2 : Protein-protein interactions of UL36 and UL37 with virus and cellular proteins. Protein-protein interactions are critical for a variety of viral and cellular processes. The UL36 and UL37 encoded polypeptides will be used as probes to identify protein-protein interactions using a combination of cell biology (cellular localization), genetic (yeast two-hybrid), biochemical (protein pull-down) assays.
Specific Aim 3 : Structural studies of UL36 and UL37 in capsids and the mature virion. A capsid binding assay and cryo-electron tomography imaging of virions will illuminate the association of these proteins with a multi-protein assembly (capsid/virion). Structural data is important for understanding how these proteins function in virus egress.
Specific Aim 4 : Identification of functional domains of UL36 and UL37. Transposon and site-directed mutagenesis will be used to identify functional domains of the UL36 and UL37 genes. Genetic complementation assays will be used to screen the mutants for functional activity. Mutations that specify lethal defects in function will be introduced into the virus using a marker-rescue/marker-transfer method. The outcome will be a functional map of UL36 and UL37 that identifies domains important for capsid translocation, Golgi stabilization, Golgi trafficking, virion incorporation and protein-protein interactions This analysis will identify domains of the proteins that have the potential to be used as targets for antiviral intervention ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI061382-01A2
Application #
7105944
Study Section
Virology - B Study Section (VIRB)
Program Officer
Beisel, Christopher E
Project Start
2006-04-01
Project End
2011-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
1
Fiscal Year
2006
Total Cost
$340,434
Indirect Cost
Name
Johns Hopkins University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Etienne, Lyns; Joshi, Poorval; Dingle, Laura et al. (2017) Visualization of herpes simplex virus type 1 virions using fluorescent colors. J Virol Methods 241:46-51
Geoghegan, Eileen M; Zhang, Hong; Desai, Prashant J et al. (2015) Antiviral activity of a single-domain antibody immunotoxin binding to glycoprotein D of herpes simplex virus 2. Antimicrob Agents Chemother 59:527-35
Bera, Alakesh; Perkins, Edward M; Zhu, Jian et al. (2014) DNA binding and condensation properties of the herpes simplex virus type 1 triplex protein VP19C. PLoS One 9:e104640
Jambunathan, Nithya; Chouljenko, Dmitry; Desai, Prashant et al. (2014) Herpes simplex virus 1 protein UL37 interacts with viral glycoprotein gK and membrane protein UL20 and functions in cytoplasmic virion envelopment. J Virol 88:5927-35
Capuano, Christopher M; Grzesik, Peter; Kreitler, Dale et al. (2014) A hydrophobic domain within the small capsid protein of Kaposi's sarcoma-associated herpesvirus is required for assembly. J Gen Virol 95:1755-69
Kalu, Nene N; Desai, Prashant J; Shirley, Courtney M et al. (2014) Nelfinavir inhibits maturation and export of herpes simplex virus 1. J Virol 88:5455-61
Hu, Shaohui; Feng, Yingzhu; Henson, Brandon et al. (2013) VirD: a virion display array for profiling functional membrane proteins. Anal Chem 85:8046-54
Luitweiler, Eric M; Henson, Brandon W; Pryce, Erin N et al. (2013) Interactions of the Kaposi's Sarcoma-associated herpesvirus nuclear egress complex: ORF69 is a potent factor for remodeling cellular membranes. J Virol 87:3915-29
Desai, Prashant J; Pryce, Erin N; Henson, Brandon W et al. (2012) Reconstitution of the Kaposi's sarcoma-associated herpesvirus nuclear egress complex and formation of nuclear membrane vesicles by coexpression of ORF67 and ORF69 gene products. J Virol 86:594-8
Kreitler, Dale; Capuano, Christopher M; Henson, Brandon W et al. (2012) The assembly domain of the small capsid protein of Kaposi's sarcoma-associated herpesvirus. J Virol 86:11926-30

Showing the most recent 10 out of 17 publications